domingo, 23 de junio de 2019

Compounding pharmacies will be harmed by FDA's overreach - STAT

Compounding pharmacies will be harmed by FDA's overreach - STAT

First Opinion

FDA’s overreach will harm compounding pharmacies and the patients they serve

By SCOTT BRUNNER


ADOBE
Compounding pharmacies across the country could be crippled by an FDA memorandum of understanding that all but halts their common practices.

No hay comentarios: